Retatrutide
A triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors, among the most studied next-generation metabolic research compounds.
When a customer purchases a peptide, it comes in powder form; we provide a vial of bacteriostatic water for reconstitution and use.
Cada peptídeo + 1 vial water freeLaboratory Spec Sheet
Reagent Synthesis Profile
Retatrutide is a unimolecular triple-receptor agonist, engineered to act on GIP, GLP-1, and glucagon receptor pathways simultaneously. It represents one of the most closely watched compounds in current metabolic and incretin research.
Our 5mg vial is manufactured to research-grade specifications and independently tested for identity and purity.
Shipped lyophilized for stability, with a free bacteriostatic water vial included for reconstitution.
Product FAQ
What receptors does Retatrutide target?＋
It is engineered to act on GIP, GLP-1, and glucagon receptors simultaneously.
How does the 5mg vial compare to the 10mg vial?＋
The 5mg vial suits smaller research batches; the 10mg vial provides more material for larger studies at a lower per-mg cost.
